2024-03-11| Asia-Pacific

Tech Titans, ASUS, Quanta and Gigabyte, Anticipate Groundbreaking Medical AI Developments at IBMI 2024 Annual General Meeting

by GeneOnline
Share To
(Provided by IBMI)

This year’s Annual General Meeting kicked off with an impressive start, as major industry giants, ASUS, Quanta and Gigabyte shared valuable insights surrounding innovative developments shaping the future of medical AI.

Barry Lam, the Vice President of the Institute for Biotechnology and Medicine Industry (IBMI) and founder of Quanta Computer shared his ideas supporting this ground-breaking technology. Emphasizing the transformative potential of generative AI, he underscored its capacity to revolutionize the medical landscape, presenting innovative strategies poised to reshape the health industry. Urging academia, healthcare systems, and the IT industry to unite in interdisciplinary collaboration, he advocated for harnessing the combined power of AI and IT to effectively address pressing medical challenges.

Revolutionizing Precision Healthcare: A Healthcare 4.0 Initiative with Innovative AI Developments at the Forefront

As a leading driver in the development of AI Healthcare, ASUS has fueled promising directions of industrial change through their generative AI (Gen AI) solutions. Using deep learning techniques to analyze data patterns through unsupervised learning models, this novel technology can create new content with greater autonomy, essentially revolutionizing corporate operations and transforming entire sectors at an unprecedented pace. 

ASUS Chairman, Johnny Shih, emphasized the importance of AI in medical development, unveiling the Healthcare 4.0 initiative as a key catalyst shaping the landscape of future healthcare services. He stressed the crucial role of AI in fostering future healthcare progress, focusing on the ability to enhance and streamline the digital transformations within the hospital domain. With the primary directive aimed at forging intelligent healthcare systems that seamlessly integrate virtual and physical dimensions, these cutting-edge innovations will pioneer a new era of healthcare services.

Given the accelerated development of digital technologies in the life science and medical care industries, Mr. Shih underscored the transformative nature of these technologies in not only addressing critical challenges but also advancing virtual growth. These novel developments can pave the way for personalized precision health, widespread virtual care, and enhanced operational resilience for healthcare institutions.

Bridging Urban-Rural Healthcare Gaps and Aging Challenges with AI: Leveraging Data, Computing, and Algorithms in Healthcare

Just as importantly, the interdependent and harmonious relationship between data, computing power, and algorithms in driving AI development was spotlighted in the commentary of Pei-Chen Yeh, Chairman of Gigabyte. Here, he highlighted that with the abundance of medical data within the National Health Insurance system of Taiwan, alongside the comprehensive experience of local medical professionals, the integration of cutting-edge technologies can drive the implementation of numerous strategies to address pressing issues such as that of aging populations and urban-rural healthcare disparities.

The discussion underscored the critical importance of adapting comprehensive health protection to modern product and service components, extending beyond basic medical services. Mr. Yeh expressed confidence in the widespread adoption of AI applications in the future, emphasizing that achieving this goal is attainable through the establishment of a big data repository and implementation of AI analytics. The adoption of these systems will inevitably provide substantial support for the advancement of medicine and pharmaceuticals, offering ICT companies an opportune moment to leverage their strengths.

Taiwan’s Healthcare Expo+ Leads as APAC’s Premier AI Healthcare Event with Cutting-Edge Medical Technology Advancements

Taiwan spearheads the advancement of medical technology for precision and preventive medicine. Yearly, the Expo unites global tech leaders like Acer, ASUS, Inventec, Quanta, Quisda, and Wistron to exhibit cutting-edge healthcare applications.

The Healthcare+ Expo, initiated by IBMI, has quickly risen to become one of the country’s top six international trade fairs since its inception in 2017. With over 600 exhibitors and 180,000 visitors annually, the Expo brings together leading global tech firms and the biomedical industry to accelerate digital transformation in healthcare. Now in its eighth year, the Expo continues to showcase state-of-the-art applications in Healthtech, Medtech, and Biotech, serving as a pivotal APAC platform for forging strategic alliances and driving innovation in the digital health economy.

Original: IBMI

Written: Bernice Lottering

© All rights reserved. Collaborate with us:
Related Post
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
AI-Driven Breakthroughs in Drug Discovery and Treatment Optimization
AI-Designed Antibodies: A Revolution in Antibody Drug Discovery
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top